Skip to content

Drug interactions

Ruxolitinib + Tazemetostat

Severity: Minor

Ruxolitinib and Tazemetostat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tazemetostat is a weak CYP3A4 inducer and may modestly lower ruxolitinib exposure. Clinical significance is likely small but loss of efficacy is possible.

What this interaction means in plain words

Ruxolitinib and Tazemetostat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ruxolitinib belongs to Oncology; Tazemetostat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Tazemetostat weakly induces CYP3A4, slightly increasing ruxolitinib metabolism.

What to do

Monitor response to ruxolitinib; no routine dose change is needed unless efficacy declines.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ruxolitinib and Tazemetostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ruxolitinib with Tazemetostat?

MediHelp rates the interaction as minor. Ruxolitinib and Tazemetostat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tazemetostat is a weak CYP3A4 inducer and may modestly lower ruxolitinib exposure. Clinical significance is likely small but loss of efficacy is possible.

How serious is the interaction between Ruxolitinib and Tazemetostat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor response to ruxolitinib; no routine dose change is needed unless efficacy declines.

What other medicines interact with Ruxolitinib?

MediHelp also lists interactions of Ruxolitinib with, for example, Atazanavir, Ceritinib, Chloramphenicol. The full list is on the Ruxolitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in